Intra-Cellular Therapies, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 11.08 M | $925.10 M | -0.41% | 10.47% |
VANGUARD GROUP INC | 02/11/2025 | 9.72 M | $811.93 M | 0.97% | 9.19% |
BLACKROCK, INC. | 02/07/2025 | 6.11 M | $510.53 M | -1.71% | 5.78% |
JPMORGAN CHASE & CO | 02/12/2025 | 5.13 M | $428.13 M | -3.03% | 4.85% |
WASATCH ADVISORS LP | 02/13/2025 | 3.25 M | $271.34 M | -15.58% | 3.07% |
NORGES BANK | 02/12/2025 | 3.21 M | $268.35 M | 100.00% | 3.04% |
INVESCO LTD. | 02/13/2025 | 3.08 M | $257.01 M | 2.93% | 2.91% |
AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 3.05 M | $254.74 M | 0.00% | 2.88% |
BELLEVUE GROUP AG | 02/14/2025 | 2.44 M | $203.81 M | -1.83% | 2.31% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 2.00 M | $167.04 M | 24.95% | 1.89% |
STATE STREET CORP | 02/14/2025 | 1.87 M | $156.59 M | 0.86% | 1.77% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.78 M | $148.41 M | 1.35% | 1.68% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.72 M | $143.43 M | 0.50% | 1.62% |
CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 1.69 M | $140.85 M | -2.51% | 1.59% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.54 M | $128.66 M | -4.87% | 1.46% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.44 M | $120.19 M | 0.00% | 1.36% |
GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 1.39 M | $115.88 M | -0.48% | 1.31% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.29 M | $107.60 M | -20.58% | 1.22% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2025 | 1.22 M | $101.79 M | 5.12% | 1.15% |
HOLOCENE ADVISORS, LP | 02/14/2025 | 1.20 M | $100.08 M | -12.59% | 1.13% |
MARSHALL WACE, LLP | 02/13/2025 | 1.08 M | $90.18 M | -7.00% | 1.02% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 1.06 M | $88.24 M | -12.56% | 1.00% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 1.03 M | $86.34 M | 1.58% | 0.98% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 915,361 | $76.45 M | 100.00% | 0.87% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 906,646 | $75.72 M | 0.19% | 0.86% |
MORGAN STANLEY | 02/14/2025 | 892,386 | $74.53 M | 6.72% | 0.84% |
TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/03/2025 | 840,269 | $70.18 M | 91.81% | 0.79% |
DEUTSCHE BANK AG\ | 02/14/2025 | 776,028 | $64.81 M | -10.47% | 0.73% |
FIRST TRUST ADVISORS LP | 02/13/2025 | 766,134 | $63.99 M | 12.63% | 0.72% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 743,230 | $62.04 M | -19.58% | 0.70% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 678,000 | $56.63 M | 266.49% | 0.64% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 615,161 | $51.38 M | 2.53% | 0.58% |
NORTHERN TRUST CORP | 02/14/2025 | 609,777 | $50.93 M | 23.96% | 0.58% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 589,906 | $49.27 M | -43.41% | 0.56% |
PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 550,963 | $46.02 M | -7.82% | 0.52% |
MACQUARIE GROUP LTD | 02/14/2025 | 544,532 | $45.48 M | -22.95% | 0.51% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 536,781 | $44.83 M | 16.23% | 0.51% |
D. E. SHAW & CO., INC. | 02/14/2025 | 534,461 | $44.64 M | 44.97% | 0.51% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 522,563 | $43.64 M | -1.44% | 0.49% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 520,826 | $43.50 M | 4.31% | 0.49% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 519,253 | $43.37 M | 6.42% | 0.49% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 519,083 | $43.35 M | 14.20% | 0.49% |
LORD, ABBETT & CO. LLC | 02/14/2025 | 516,719 | $43.16 M | -17.83% | 0.49% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 451,146 | $37.68 M | -51.55% | 0.43% |
EMERALD ADVISERS, LLC | 02/11/2025 | 438,066 | $36.59 M | -0.73% | 0.41% |
WALLEYE CAPITAL LLC | 02/13/2025 | 383,591 | $32.04 M | 53.81% | 0.36% |
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 02/18/2025 | 380,423 | $31.77 M | -5.99% | 0.36% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 376,417 | $31.44 M | -17.46% | 0.36% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 369,617 | $30.87 M | 5.78% | 0.35% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 364,370 | $30.43 M | -13.76% | 0.34% |
Intra-Cellular Therapies, Inc. institutional Ownership - FAQ's
During the previous two years, 465 institutional investors and hedge funds held shares of Intra-Cellular Therapies, Inc.. The most heavily invested institutionals were:
FIRST HAWAIIAN BANK: 0
FULTON BANK, N.A.: 0
FMR LLC: 11.08 M
VANGUARD GROUP INC: 9.72 M
BlackRock, Inc.: 6.11 M
JPMORGAN CHASE & CO: 5.13 M
91.46% of Intra-Cellular Therapies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 114.11 M shares in the last 24 months. This purchase volume represents approximately $15.05 B in transactions.